High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer
The aim of this study is the safety and efficacy of high-activity natural killer immunotherapy to small metastases of pancreatic cancer.
Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer
The aim of this study is the safety and efficacy of irreversible electroporation (IRE) plus natural killer (NK) immunotherapy to recurrent liver cancer.
High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer
The aim of this study is the safety and efficacy of high-activity natural killer immunotherapy to small metastases of non-small cell lung cancer.
100 Clinical Results associated with Shenzhen Hanke Bioengineering Co., Ltd.
0 Patents (Medical) associated with Shenzhen Hanke Bioengineering Co., Ltd.
100 Deals associated with Shenzhen Hanke Bioengineering Co., Ltd.
100 Translational Medicine associated with Shenzhen Hanke Bioengineering Co., Ltd.